TNDM today
$18.77+$0.06 (+0.32%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourExpanding
1 hourLeaning Bearish
15 minStrong Bullish
5 minStrong Bearish
Daily trend turns down below $14.83
Key levels
Resistance$20.25
Resistance$18.90
Support$17.61
Support$15.61
Latest news & SEC filings
AnalystBarclays keeps Equal-Weight rating on Tandem Diabetes Care, lifts target to $20
AnalystWells Fargo keeps Overweight rating on Tandem Diabetes Care, cuts target to $25
All TNDM news →About Tandem Diabetes Care
Tandem Diabetes Care makes insulin delivery devices for people with insulin-dependent diabetes. Its pump platforms include a slim durable model and a smaller wearable pump, both paired with the company's automated insulin dosing algorithm and compatible with continuous glucose monitors. The company also provides therapy data software and a mobile app. It sells directly in the United States and Canada and through distributors in over 25 countries.
Based on the company's 10-K filed Feb 19, 2026.
Nasdaq · Healthcare
TANDEM DIABETES CARE INC (TNDM)
What Is the Price Target for TNDM?
SEPT Low Target
$15.50
SEPT Mid Target
$25.00
SEPT High Target
$31.00
Analyst Consensus
$25.00
Is TNDM a Buy or Sell Right Now?
Thesis
- •Revenue growing 7.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TNDM.
Start Free Trial →Is TNDM Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$20.00
30
Moat Score
NONE
3/9
Piotroski Score
0.0
Altman Z-Score
What Is Smart Money Doing with TNDM?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
BUYING
4 buys / 1 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| TWOMEY CHRISTOPHER J | director | Buy | 1,700 | $32K | Oct 27, 2026 |
| TWOMEY CHRISTOPHER J | director | Sale | 1,700 | $33K | Oct 27, 2026 |
| Gasser Elizabeth Anne | officer | Sale | 7,160 | - | Jun 2, 2026 |
| Allen Dick | other | Buy | 8,759 | - | May 21, 2026 |
| Howell Peyton R | director | Buy | 8,759 | - | May 21, 2026 |
| Malagueira Joao Paulo Falcao | director | Buy | 8,759 | - | May 21, 2026 |
| Sodhi Rajwant | director | Buy | 8,759 | - | May 21, 2026 |
| McGroddy-Goetz Kathleen | director | Buy | 8,759 | - | May 21, 2026 |
| ROBERTSON REBECCA B | director | Buy | 8,759 | - | May 21, 2026 |
| TWOMEY CHRISTOPHER J | director | Buy | 8,759 | - | May 21, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TNDM Growth Story
Revenue YoY
7.9%
3yr Revenue CAGR
8.2%
EPS Growth YoY
-106.8%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for TNDM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TNDM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:54 | $18.77 | 10,657 | $$200K | BUY |
| 21:00:54 | $18.77 | 1,534 | $$29K | BUY |
| 21:00:53 | $18.77 | 1,735 | $$33K | BUY |
| 21:00:53 | $18.77 | 3,758 | $$71K | BUY |
| 21:00:53 | $18.77 | 15,399 | $$289K | BUY |
5 dark pool trades shown · $$621K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for TNDM
PREVIEWSEPT Investing provides real-time options flow tracking for TNDM, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $14 | Nov 20 | 9 | $$10 | 2 | SWEEP |
1 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for TANDEM DIABETES CARE INC (TNDM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TNDM — frequently asked questions
What is TNDM stock price today?
TANDEM DIABETES CARE INC (TNDM) is at $18.77, up 0.32% (+$0.06) at the Nov 11, 2026 close.
Why is TNDM stock moving today?
Latest TNDM news — Nov 6, 2026: Barclays keeps Equal-Weight rating on Tandem Diabetes Care, lifts target to $20 · Nov 6, 2026: Wells Fargo keeps Overweight rating on Tandem Diabetes Care, cuts target to $25
What is the TNDM price target?
The average analyst price target for TNDM is $25.00, ranging from $16 to $31, based on 11 analysts. Latest: Wells Fargo maintains on Nov 6, 2026.
What do analysts rate TNDM?
Analyst ratings for TNDM: 1 Buy, 16 Hold, 0 Sell — consensus Hold.
Did TNDM beat earnings?
TNDM last reported on Nov 5, 2026: EPS -$0.10 vs -$0.25 expected — a beat of 59.2%.
Does TNDM pay a dividend?
TNDM does not currently pay a dividend.
What are TNDM support and resistance levels?
Support: $17.61, $15.61, $13.95. Resistance: $18.90, $20.25, $22.30.
What are insiders doing with TNDM?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on TNDM?
Nov 6, 2026: Barclays keeps Equal-Weight rating on Tandem Diabetes Care, lifts target to $20 · Nov 6, 2026: Wells Fargo keeps Overweight rating on Tandem Diabetes Care, cuts target to $25